Emmaus Life Sciences, Inc. Quarterly Interest Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2018 to Q3 2024.
  • Emmaus Life Sciences, Inc. Interest Expense for the quarter ending September 30, 2024 was $1.34M, a 29.9% decline year-over-year.
  • Emmaus Life Sciences, Inc. Interest Expense for the twelve months ending September 30, 2024 was $6.39M, a 4.2% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2023 was $7.38M, a 47.3% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2022 was $5.01M, a 61.7% increase from 2021.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2021 was $3.1M, a 48.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.39M $1.34M -$571K -29.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $6.96M $966K -$827K -46.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-10
Q1 2024 $7.79M $1.91M +$408K +27.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-10
Q4 2023 $7.38M $2.18M +$710K +48.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-07-03
Q3 2023 $6.67M $1.91M +$389K +25.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 $6.28M $1.79M +$506K +39.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-10
Q1 2023 $5.78M $1.5M +$765K +104% Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-10
Q4 2022 $5.01M $1.47M +$758K +107% Oct 1, 2022 Dec 31, 2022 10-K 2024-07-03
Q3 2022 $4.26M $1.52M +$837K +123% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.42M $1.29M +$634K +97.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.78M $737K -$317K -30.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $3.1M $711K -$563K -44.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.66M $683K -$923K -57.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.59M $653K -$656K -50.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $5.24M $1.05M -$746K -41.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $5.99M $1.27M -$1.2M -48.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $7.19M $1.61M -$7.11M -81.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $14.3M $1.31M -$6.52M -83.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-01
Q1 2020 $20.8M $1.8M -$6.81M -79.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-01
Q4 2019 $27.6M $2.47M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-08-10
Q3 2019 $8.71M +$3.19M +57.7% Jul 1, 2019 Sep 30, 2019 10-Q 2021-08-26
Q2 2019 $7.83M +$2.38M +43.7% Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-26
Q1 2019 $8.61M Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-26
Q3 2018 $5.53M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $5.45M Apr 1, 2018 Jun 30, 2018 8-K/A 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.